ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

07-03 - Ex-dividend date - 0.11 EUR

More about the company

Quotes

Date	Price	Change	Volume
12/06/26	2.720 €	+5.43%	45,090
11/06/26	2.580 €	-0.77%	7,721
10/06/26	2.600 €	-0.76%	10,275
09/06/26	2.620 €	-3.68%	5,032
08/06/26	2.720 €	-2.16%	8,215

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris Other stock markets 19:55:00 12/06/2026 +04			5-day change	1st Jan Change
2.720 ^EUR	+5.43%		-2.16%	-9.33%

06-12	Abl Diagnostics Sa and Cdl Pharma Secure Multi-Year International Contract of Up to Eur 2.7 Million Through 2031	CI
06-12	ABL Diagnostics Signs Multi-year Contract to Provide Clinical Trial Services	MT

Market Cap	43.71M 50.61M 40.28M 37.7M 70.66M 4.81B 71.75M 476M 185M 2.34B 190M 186M 8.11B	P/E Ratio 2024	123x	P/E Ratio 2025	50x
Enterprise Value	44.64M 51.69M 41.14M 38.51M 72.16M 4.91B 73.28M 486M 189M 2.39B 194M 190M 8.28B	EV / Sales 2024	7,098,474x	EV / Sales 2025	6,185,843x
Free-Float	2.52%	Yield 2024	2.03%	Yield 2025	3.67%

06-12	Abl Diagnostics Sa and Cdl Pharma Secure Multi-Year International Contract of Up to Eur 2.7 Million Through 2031	CI
06-12	ABL Diagnostics Signs Multi-year Contract to Provide Clinical Trial Services	MT
06-12	ABL Diagnostics Secures Multi-Year Contract with CDL Pharma
06-10	ABL Diagnostics Offers to Buy Texcell	MT
06-05	ABL divests block of ABL Diagnostics shares
06-02	ABL Diagnostics Société anonyme Provides Earnings Guidance for the Fiscal Year Ending December 31, 2026	CI
05-18	ABL Diagnostics Société anonyme Proposes Dividend for the Financial Year Ended December 31, 2025, Payable on July 7, 2026	CI
05-07	ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-14	Abl Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its Vela Product Line in A Targeted Segment of the French Market	CI
01/10/25	ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
06/08/25	ABL Diagnostics Société anonyme announced that it expects to receive funding from Alumni Capital Management	CI
09/05/25	ABL Diagnostics Société anonyme announces Annual dividend, payable on July 01, 2025	CI
06/05/25	ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	CI

06-12	ABL Diagnostics and CDL Pharma Secure a Multi-year International Contract of up to €2.7 Million Through 2031	BU
06-10	ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France	BU
06-09	ABL Diagnostics: Ordinary and Extraordinary General Meeting of June 30, 2026 – Terms for Making Available or Consulting Preparatory Documents	BU
06-05	ABL Diagnostics: Sale of a new block of shares by its main shareholder ABL	BU
06-04	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL	BU

ABL Diagnostics Stock

Stocks

ABLD

FR001400AHX6

Medical Equipment, Supplies & Distribution

Valuation: ABL Diagnostics

Chart: ABL Diagnostics

Latest news : ABL Diagnostics

Press Releases: ABL Diagnostics

News in other languages: ABL Diagnostics

Quotes and Performance

Course Extremes

Managers and Directors: ABL Diagnostics

Latest insider transactions

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

06-12	ABL Diagnostics remporte un contrat pluriannuel avec CDL Pharma
06-12	ABL Diagnostics et CDL Pharma remportent un contrat international pluriannuel pouvant atteindre 2,7 M€ jusqu’en 2031
06-10	ABL Diagnostics (ABLD) annonce le dépôt d’une offre de reprise de Texcell France
06-09	ABL Diagnostics : Assemblée Générale Ordinaire et Extraordinaire du 30 juin 2026 – Modalités de mise à disposition ou de consultation des documents préparatoires
06-05	ABL Diagnostics : Cession d'un nouveau bloc d'actions par son actionnaire principal ABL

1 day	+5.43%
1 week	-2.16%
Current month	-20.47%
1 month	-30.26%
3 months	-22.73%
6 months	-12.26%
Current year	-9.33%

1 week	2.46	2.9
1 month	2.46	4.02
Current year	2.12	5
1 year	2.12	5.75
3 years	2.12	9.7
5 years	1.99	26
10 years	1.28	26

Director	Title	Age	Since
Noemie Sadoun CHM	Chairman	-	-
Laure Raffaelli BRD	Director/Board Member	-	-
Deborah Szafir BRD	Director/Board Member	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
06-02	Advanced Biological Laboratories SA	Sell	Company	-57,692	0.3580%
05-27	Advanced Biological Laboratories SA	Sell	Company	-51,900	0.3221%
03-17	Advanced Biological Laboratories SA	Sell	Company	54,745	0.3397%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ABL DIAGNOSTICS	+5.43%	-2.16%	-50.09%	-42.13%	50.61M
ABBOTT LABORATORIES	-1.64%	-3.17%	-34.98%	-13.43%	154B
MEDTRONIC PLC	-0.16%	-1.80%	-8.10%	-6.47%	103B
HOYA CORPORATION	+3.00%	+0.30%	+58.58%	+48.55%	55.22B
CENCORA, INC.	+0.07%	+2.41%	-4.69%	+56.67%	54.8B
BECTON, DICKINSON AND COMPANY	-0.75%	-3.25%	-15.08%	-41.85%	40.3B
MEDLINE INC.	-1.40%	+8.93%	-	-	30.96B
DEXCOM, INC.	+0.16%	+3.44%	-8.07%	-40.16%	29.08B
WEST PHARMACEUTICAL SERVICES, INC.	-0.46%	+4.55%	+48.18%	-8.10%	23.23B
TERUMO CORPORATION	-2.85%	-3.53%	-15.70%	-1.83%	20.25B
Average	+0.14%	+0.70%	-3.33%	-5.42%	51.05B
Weighted average by Cap.	-0.46%	-0.31%	-6.82%	-0.05%

	2024	2025
Net sales	5.87 6.8 5.41 5.06 9.49 645.93 9.63 63.86 24.9 314.4 25.5 24.96 1.09K	7.97 9.22 7.34 6.87 12.88 876.63 13.08 86.67 33.79 426.69 34.61 33.88 1.48K
Net income	285K 330K 263K 246K 461K 31.38M 468K 3.1M 1.21M 15.28M 1.24M 1.21M 52.89M	987K 1.14M 909K 851K 1.59M 109M 1.62M 10.74M 4.19M 52.85M 4.29M 4.2M 183M
Net Debt	2.02M 2.34M 1.86M 1.75M 3.27M 223M 3.32M 22.02M 8.59M 108M 8.79M 8.61M 375M	933K 1.08M 859K 804K 1.51M 103M 1.53M 10.15M 3.96M 49.96M 4.05M 3.97M 173M